As of June 12, 2025, Mckesson Corp (MCK) reports a EV/EBITDA of 15.88.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Mckesson Corp's EV/EBITDA to Peers
To better understand Mckesson Corp's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Mckesson Corp (MCK) | 15.88 |
| Owens & Minor Inc (OMI) | 86.97 |
| Amexdrug Corp (AXRX) | 40.64 |
| Oriola Oyj (OKDBV.HE) | 23.21 |
| Medcom Tech SA (MED.MC) | 16.20 |
| PetIQ Inc (PETQ) | 14.36 |
Compared to its competitors, Mckesson Corp's EV/EBITDA is among the highest compared to peers, suggesting the market values the company at a premium, possibly due to growth expectations.